Evidence map›Paper›PMID 26935652›Full record

Trial reportScientific reports2016

Neurophysiological responses to unpleasant stimuli (acute electrical stimulations and emotional pictures) are increased in patients with schizophrenia.

Céline Z Duval, Yannick Goumon, Véronique Kemmel, Jürgen Kornmeier, André Dufour, Olivier Andlauer, Pierre Vidailhet, Pierrick Poisbeau, Eric Salvat, André Muller and 3 more

Abstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Céline Z DuvalINSERM U-1114, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg; 1, place de l'Hôpital, 67000 Strasbourg, France.
Yannick GoumonInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR 3212, 5, rue Blaise Pascal, 67084 Strasbourg, France.
Véronique KemmelINSERM U-1119 Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, 11 rue Humann, 67000 Strasbourg, France.
Jürgen KornmeierInstitute for Frontier Areas of Psychology and Mental Health, 79098 Freiburg, Germany.
André DufourLaboratoire de Neurosciences Cognitives et Adaptatives, UMR 7364, Université de Strasbourg, CNRS, Strasbourg, France.
Olivier AndlauerEA 481 Laboratoire de Neurosciences, Université de Franche-Comte, 1 place du maréchal Leclerc, 25030 Besançon Cedex, France.
Pierre VidailhetINSERM U-1114, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg; 1, place de l'Hôpital, 67000 Strasbourg, France.
Pierrick PoisbeauInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR 3212, 5, rue Blaise Pascal, 67084 Strasbourg, France.
Eric SalvatInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR 3212, 5, rue Blaise Pascal, 67084 Strasbourg, France.
André MullerInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR 3212, 5, rue Blaise Pascal, 67084 Strasbourg, France.
Ayikoé G Mensah-NyaganINSERM U-1119 Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, 11 rue Humann, 67000 Strasbourg, France.
Catherine Schmidt-MutterFondation FondaMental, Créteil, France.
Anne GierschINSERM U-1114, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Département de Psychiatrie, Hôpitaux Universitaires de Strasbourg; 1, place de l'Hôpital, 67000 Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with schizophrenia have often been described as insensitive to nociceptive signals, but objective evidence is sparse. We address this question by combining subjective behavioral and objective neurochemical and neurophysiological measures. The present study involved 21 stabilized and mildly symptomatic patients with schizophrenia and 21 control subjects. We applied electrical stimulations below the pain threshold and assessed sensations of pain and unpleasantness with rating scales, and Somatosensory Evoked Potentials (SEPs/EEG). We also measured attention, two neurochemical stress indices (ACTH/cortisol), and subjective VEPs/EEG responses to visual emotional stimuli. Our results revealed that, subjectively, patients' evaluations do not differ from controls. However, the amplitude of EEG evoked potentials was greater in patients than controls as early as 50 ms after electrical stimulations and beyond one second after visual processing of emotional pictures. Such responses could not be linked to the stress induced by the stimulations, since stress hormone levels were stable. Nor was there a difference between patients and controls in respect of attention performance and tactile sensitivity. Taken together, all indices measured in patients in our study were either heightened or equivalent relative to healthy volunteers.

Indexed as

ElectroencephalographyEmotionsEvoked Potentials, SomatosensoryAdultElectric StimulationFemaleHumansMaleMiddle AgedPainSchizophreniaStress, Psychological

Identifiers

PMID26935652
PMCPMC4776095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.